ClinicalTrials.gg
RecruitingNCT06735170Updated Jan 7, 2026

Tuberoplasty Versus Balloon Spacer

A Phase 1/2 interventional study of biologic tuberoplasty and subacromial balloon spacer in Rotator Cuff Tears, sponsored by University of Minnesota. Recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by University of Minnesota · Phase 1/2, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 1/2
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 168 studies in Rotator Cuff Injuries with a site in United States — 40 open to participants now, 50 under way, none of them phase 3. Rotator Cuff Injuries · United States.

Planned enrollment
88th of 130
40 · median 60
Started
2024
with 10 others
Phase 1/2
3 of 168
2 open now
Primary completion
2026-11
later than 12 of 49 live
Registered
153rd of 168
by date

Among the 168 studies in Rotator Cuff Injuries with a site in United States, this one is the 88th largest by planned enrollment of the 130 interventional ones that give a count, is one of 11 that started in 2024, is one of 3 in phase 1/2, reaches primary completion later than 12 of the 49 other live ones, and was the 153rd registered.

Rotator Cuff Injuries

632 studies on the registry are indexed under Rotator Cuff Injuries; 157 are open to participants now.

Browse Rotator Cuff Injuries studies →

Open to participants now

40 of the 168 studies in Rotator Cuff Injuries with a site in United States are open now. Recruiting first, the newest first:

34 more — sign in →

All 40 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 168 studies in Rotator Cuff Injuries with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to examine bone-to-bone contact between the tuberosity as compared to a subacromial balloon spacer procedure. Using biplanar fluoroscopy to determine the three-dimensional (3D) motion of the shoulder compared pre-procedure to post-procedure, the investigators will be able to assess 1) the bone-to-bone contact of the tuberosity and acromion in the setting of a massive posterior superior rotator cuff tear 2) if the placement of a dermal allograft over the tuberosity does indeed decrease bone contact and 3) if the placement of a subacromial balloon spacer decreases bone-to-bone contact. Doing so will allow assessment of the relative contribution of the implant for arm elevation versus potential compensatory motion of increased scapulothoracic motion. The investigators will also be able to correlate this to patient-reported outcomes of pain and shoulder function.

03

Conditions studied

  • Rotator Cuff Tears

Browse trials for

Keywords

  • rotator cuff tear
  • shoulder surgery
  • tuberoplasty
  • subacromial balloon spacer
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Massive irreparable rotator cuff tear involving the supraspinatus and infraspinatus.
  • No involvement of the subscapularis.
  • Centered humeral head on X-ray examination.
  • Primary complaint of pain.
  • History of prior surgery, including failed rotator cuff repair.

Exclusion criteria

Exclusion Criteria:

  • Involvement of the subscapularis.
  • Acromiohumeral distance less than 7 mm on upright anterior-posterior (AP) radiograph.
  • Rotator cuff deemed repairable at the time of surgery.
  • Patients younger than 65 years due to FDA clearance of the subacromial balloon spacer only for patients over 65
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    biologic tuberoplasty group

    massive irreparable rotator cuff tear involving the supraspinatus and infraspinatus, no involvement of the subscapularis, centered humeral head on X-Ray examination, and a primary complaint of pain, randomized to biologic tuberoplasty surgery.

    Procedure: biologic tuberoplasty

  • Experimental
    subacromial balloon spacer group

    massive irreparable rotator cuff tear involving the supraspinatus and infraspinatus, no involvement of the subscapularis, centered humeral head on X-Ray examination, and a primary complaint of pain, randomized to subacromial balloon spacer.

    Procedure: subacromial balloon spacer

Interventions

  • Procedurebiologic tuberoplasty

    a surgical procedure during which an a cellular dermal allograft is attached to the greater tuberosity to prevent bone-to-bone contact between the greater tuberosity and the acromion with the goal of decreasing pain

  • Proceduresubacromial balloon spacer

    a biodegradable balloon is inserted into the subacromial space of the shoulder to increase teh distance between the greater tuberosity and the acromion to reduce pain

06

What researchers measure

Primary outcomes

  1. change in bone-to-bone contact between tuberosity and acromion

    degree of change in bone-to-bone contact between tuberosity and acromion as assessed using biplanar fluoroscopy

    Time frame: presurgery, 6 months postop, 12 months postop

  2. shoulder range of motion

    quantitative measurement in degrees with a goniometer of shoulder motion in forward elevation, abduction, external rotation, and internal rotation

    Time frame: presurgery, 1 week, 6 weeks, 3 months, 6 months, and 12 months postoperatively

  3. single assessment numerical evaluation (SANE) of the shoulder

    a validated tool providing a numerical score from 0-100 that assess shoulder function as subjectively reported by the subject. A higher score indicates superior shoulder function.

    Time frame: presurgery, 1 week, 6 weeks, 3 months, 6 months, and 12 months postoperatively

  4. American shoulder and elbow surgeons (ASES) score

    a validated survey with possible scores from 0-100 that assesses shoulder function as reported by the subject. A higher score indicates superior shoulder function.

    Time frame: presurgery, 1 week, 6 weeks, 3 months, 6 months, and 12 months postoperatively

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2024 (actual). Primary completion is estimated for Nov 2026, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 3, 2024
First posted
Dec 16, 2024
StartActual
Dec 2, 2024
Primary completionEst.
Nov 26, 2026
CompletionEst.
Nov 26, 2026
Last update
Jan 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06735170
Responsible party
Sponsor
First posted
Dec 16, 2024
Start date
Dec 2, 2024
Primary completion
Nov 26, 2026 (estimated)
Completion
Nov 26, 2026 (estimated)
Last update
Jan 7, 2026

Study contacts

Allison Rao
Contact
rao00149@umn.edu
608-445-0545
Allison Rao
principal investigator · University of Minnesota

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion